Article
Major drugmaker loses $27 billion in market value after failed trial
Bullish
65.0
−100 Bearish
0
+100 Bullish
Two companies announced on Thursday that the heart disease drug they had been developing failed its Phase III trial.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Sentiment Signal
Bullish
65.0
−100Neutral+100
More Like This